Future of the Yellow Fever Vaccine Market: Strategic Analysis and Forecast to 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Yellow Fever Vaccine Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, there has been a significant expansion in the size of the yellow fever vaccine market. The market value, which is expected to surge from $4.54 billion in 2024 to $4.79 billion in 2025, will witness a compound annual growth rate (CAGR) of 5.4%. The notable growth during the historic period is a result of the kick-off of worldwide immunization campaigns, the enforcement of international health rules, large-scale vaccination initiatives, and breakthroughs in the technology used for producing vaccines.

Yellow Fever Vaccine Market Size Forecast: What's the Projected Valuation by 2029?
The market for the yellow fever vaccine is predicted to significantly expand in the forthcoming years, reaching $5.84 billion by 2029, with a compound annual growth rate (CAGR) of 5.1%. This growth during the forecasted period is linked to factors such as enhanced collaboration and partnerships, the incorporation of the vaccine into regular immunization schedules, vigilant surveillance and monitoring, an uptick in the participation of private enterprises, and the utilization of digital technologies for vaccine tracking. The forecast period also sees dominant trends such as modification of vaccine formats, readiness for pandemics, regulatory shifts, enhancements in healthcare infrastructure, and promotion of consumer knowledge and awareness.

View the full report here:
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

What Are the Drivers Transforming the Yellow Fever Vaccine Market?
The rise in global travel is anticipated to fuel the development of the yellow fever vaccine market. Global travel, which involves individuals moving across international borders for tourism, business, or personal use, is growing due to heightened global connections, economic expansion, and the easing of travel constraints following the pandemic. The yellow fever vaccine is essential or suggested for individuals traveling to areas where the disease is prevalent in order to prevent infection and adhere to international health rules. For example, the World Tourism Organization reported in January 2024 that there were 1.286 billion overnight international tourists worldwide in 2023 compared to 960 million in 2022, indicating an increase of 326 million international tourists between 2022 and 2023. As a result, the surge in global travel is contributing to the expansion of the market for the yellow fever vaccine.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

What Long-Term Trends Will Define the Future of the Yellow Fever Vaccine Market?
Leading businesses in the yellow fever vaccine market are increasing their effort to create enhanced next-generation vaccines, including the T-cell adaptive booster vaccine, in response to the rising global demand for vaccines. The T-cell adaptive booster vaccine is designed specifically to strengthen the response of the immune system's memory T-cells, facilitating stronger and longer-lasting immunity against certain pathogens. A notable example of this is the collaboration between Emergex Vaccines Holding Limited, a biotech firm based in the UK, and ATCC, a non-profit organization from the US that supplies reference microorganisms, cell lines, and other resources for research, in April 2022. They joined forces to launch the CD8+ T-cell adaptive vaccines, specially fashioned for yellow fever, aiming to provoke a commanding cytotoxic T-cell reaction, crucial for pinpointing and wiping out cells infected with the virus. By boosting the production of memory CD8+ T-cells, these vaccines ensure robust and enduring immunity. They target cellular immune response, not merely antibody creation, hence ensuring all-round protection against yellow fever and potentially improving efficacy amidst individuals with diverse immune profiles.

Which Segments in the Yellow Fever Vaccine Market Offer the Most Profit Potential?
The yellow fever vaccine market covered in this report is segmented -

1) By Product: Powder, Liquid
2) By Treatment Type: Pain Management Drugs, Oral Rehydration
3) By Application: Routine Immunization, Travelers, Other Applications
4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=17297&type=smp

Which Firms Dominate the Yellow Fever Vaccine Market by Market Share and Revenue in 2025?
Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.

Which Regions Offer the Highest Growth Potential in the Yellow Fever Vaccine Market?
North America was the largest region in the yellow fever vaccine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17297

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.